Increased expression levels of PGC-1α and UCP1 have also been detected in mouse models of obesity that have been treated with the SGLT2 inhibitors Canagliflozin [20] and Empagliflozin [21], respectively. Here, UCP1 is linked to obesity due to melanocortin 4 receptor deficiency.